Hepatitis following Treatments with Famotidine and Then CimetIDINE
- 1 January 1994
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 28 (1) , 37-39
- https://doi.org/10.1177/106002809402800106
Abstract
OBJECTIVE: To report a case of hepatitis induced by two histamine (H2)-receptor blockers, famotidine and cimetidine. CASE SUMMARY: A 51-year-old obese woman with a duodenal ulcer developed symptomatic, famotidine-induced hepatitis. Other causes for hepatitis were ruled out. Famotidine was discontinued and the patient took omeprazole for a month without incident. Cimetidine therapy was then initiated and shortly thereafter, the patient developed another episode of symptomatic hepatitis that resolved upon drug discontinuation. Two abdominal ultrasound examinations six months apart and an abdominal computed tomography scan obtained later showed what appeared to be a stable, fatty liver. DISCUSSION: This appears to be the first reported case of clinical hepatitis related to famotidine and the first reported case where clinical hepatitis followed the administration of two different H2-receptor blockers. The fatty liver probably was secondary to obesity and incidental to the hepatitis episodes. CONCLUSIONS: Famotidine can cause clinical hepatitis, and druginduced hepatitis can occur after the administration of two different H2-receptor blockers.Keywords
This publication has 17 references indexed in Scilit:
- Side-effects, structure, and H2-receptor antagonistsThe Lancet, 1992
- Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity.Gut, 1988
- Excessive aminoglycoside nephrotoxicity in obese patientsThe American Journal of Medicine, 1988
- Hepatic Effects of AcetaminophenJournal of Clinical Gastroenterology, 1987
- Cimetidine HepatitisJournal of Clinical Gastroenterology, 1986
- Acetaminophen Hepatotoxicity in AlcoholicsAnnals of Internal Medicine, 1986
- Enhanced Toxicity of Acetaminophen in Alcoholics: Report of Three CasesJournal of Clinical Gastroenterology, 1985
- Hepatitis Associated With RanitidinePublished by American Medical Association (AMA) ,1984
- Halothane Biotransformation in Obese and Nonobese PatientsAnesthesiology, 1982
- Clinical Pharmacy: Case StudiesDrug Intelligence & Clinical Pharmacy, 1974